These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3011616)

  • 1. Beneficial effects of defibrotide against myocardial ischemia and decline of beta-adrenoceptor function in the rabbit.
    Berti F; Rossoni G; Niada R; Omini C; Pretolani M; Mandelli C
    Haemostasis; 1986; 16 Suppl 1():13-7. PubMed ID: 3011616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defibrotide, an antithrombotic substance that preserves postsynaptic alpha- and beta-adrenergic function in post acute infarcted rabbit hearts.
    Berti F; Rossoni G; Niada R; Folco G; Omini C; Tondo C
    J Cardiovasc Pharmacol; 1986; 8(2):235-40. PubMed ID: 2422459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defibrotide, an antithrombotic substance which prevents myocardial contracture in ischemic rabbit heart.
    Berti F; Rossoni G; Omini C; Folco G; Daffonchio L; Viganó T; Tondo C
    Eur J Pharmacol; 1987 Mar; 135(3):375-82. PubMed ID: 3556200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of defibrotide in protecting ischemic myocardium from early reperfusion damage.
    Thiemermann C; Löbel P; Schrör K
    Am J Cardiol; 1985 Dec; 56(15):978-82. PubMed ID: 3907318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of prostacyclin synthesis by defibrotide: improved contractile recovery from myocardial "stunning".
    Hohlfeld T; Strobach H; Schrör K
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):108-15. PubMed ID: 1708043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotective effects of defibrotide in acute lethal and nonlethal myocardial ischemia in the cat.
    Niada R; Porta R; Pescador R; Mantovani M; Prino G; Berti F
    Haemostasis; 1986; 16 Suppl 1():18-25. PubMed ID: 3519380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defibrotide protects rabbit myocardium from ischemia: relationship with the eicosanoid system.
    Berti F; Rossini G; Omini C; Daffonchio L; Tondo C; Cali G
    Pol J Pharmacol Pharm; 1987; 39(5):657-65. PubMed ID: 3506734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polydeoxyribonucleotide (defibrotide) protects against post-ischemic behavioral, electroencephalographic and neuronal damage in the gerbil.
    Sala M; Leone MP; Lampugnani P; Matturri L; Gori E
    Eur J Pharmacol; 1997 Jun; 328(2-3):143-52. PubMed ID: 9218696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of endogenous prostacyclin protects the reperfused pig myocardium from ischemic injury.
    Hohlfeld T; Strobach H; Schrör K
    J Pharmacol Exp Ther; 1993 Jan; 264(1):397-405. PubMed ID: 8423539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defibrotide reduces infarct size in a rabbit model of experimental myocardial ischaemia and reperfusion.
    Thiemermann C; Thomas GR; Vane JR
    Br J Pharmacol; 1989 Jun; 97(2):401-8. PubMed ID: 2758223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of defibrotide on infarct size and regional myocardial blood flow on the ischaemic reperfused rabbit heart.
    Thiemermann C; Thomas GR; Vane JR
    Prog Clin Biol Res; 1989; 301():131-5. PubMed ID: 2798443
    [No Abstract]   [Full Text] [Related]  

  • 12. An integrated view of the activities of defibrotide.
    Pescador R; Porta R; Ferro L
    Semin Thromb Hemost; 1996; 22 Suppl 1():71-5. PubMed ID: 8807733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology and mode of action of a new antithrombotic compound: Defibrotide.
    Ulutin ON; Cizmeci G; Balkuv-Ulutin S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):177-80. PubMed ID: 2459016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide and prostacyclin pathways: an integrated mechanism that limits myocardial infarction progression in anaesthetized rats.
    Rossoni G; Manfredi B; De Gennaro Colonna V; Brini AT; Polvani G; Clement MG; Berti F
    Pharmacol Res; 2006 Apr; 53(4):359-66. PubMed ID: 16488624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel insight into the mechanism of the antithrombotic action of defibrotide.
    Tettamanti R; Bianchi G; Vitte PA; Kato G; Porta R; Thiemermann C; Pescador R; Mantovani M
    Life Sci; 1992; 51(19):1545-55. PubMed ID: 1331634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of defibrotide on prostacyclin release from isolated rabbit kidneys and protection from post-ischemic acute renal failure in vivo.
    Berti F; Rossoni G; Bianchi G; Alberico P; Tettamanti R; Calvani AB; Mantovani M; Prino G
    Eicosanoids; 1991; 4(4):209-15. PubMed ID: 1789997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolytic effects of defibrotide in atherosclerotic patients.
    Patrassi GM; Sartori MT; Viero ML; Scapinello MP; Boeri G; Girolami A
    Semin Thromb Hemost; 1991; 17 Suppl 1():101-5. PubMed ID: 2068562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial protection by defibrotide--a new strategy for treatment of myocardial infarction?
    Schrör K; Ackermann G; Hohlfeld T; Löbel P; Ney P; Schröder H; Strobach H
    Z Kardiol; 1989; 78 Suppl 6():35-41. PubMed ID: 2559554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defibrotide reduces monocyte PAI-2 and procoagulant activity.
    Abbate R; Gori AM; Martini F; Attanasio M; Comeglio P; Giusti B; Zarone N; Francalanci I; Prisco D; Gensini GF
    Semin Thromb Hemost; 1995; 21(2):245-50. PubMed ID: 7660147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption through the peritoneum of the macromolecular profibrinolytic drug defibrotide in the rabbit.
    Porta R; Calvani AB; Pescador R; Mantovani M; Prino G
    Semin Thromb Hemost; 1991 Oct; 17(4):404-6. PubMed ID: 1803509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.